Literature DB >> 27650214

Causes of hospitalization and prognosis in patients with cardiovascular diseases. Secular trends in the years 2006-2014 according to the SILesian CARDiovascular (SILCARD) database.

Mariusz Gąsior1, Damian Pres1, Wojciech Wojakowski2, Paweł Buszman3,4, Zbigniew Kalarus5, Michał Hawranek1, Marek Gierlotka1, Andrzej Lekston1, Katarzyna Mizia-Stec6, Marian Zembala7, Lech Poloński1, Michał Tendera2.   

Abstract

INTRODUCTION Despite the progress in cardiology in recent years, cardiovascular (CV) diseases remain the main cause of death in European countries. The knowledge concerning the structure of hospital admissions for CV diseases and clinical outcomes is fragmentary. OBJECTIVES The aim of the study was to analyze the characteristics and outcome of patients with CV disease, hospitalized between 2006 and 2014 and included in the Silesian Cardiovascular Database (SILCARD) covering a population of 4.6 million patients. PATIENTS AND METHODS SILCARD is based on the data from the Regional Department of the National Health Fund in Poland. The enrollment criteria were any hospitalization at a department of cardiology, cardiac surgery, diabetology or vascular surgery and hospitalization with a cardiovascular diagnosis at a department of internal medicine or intensive care. The data come from 310 hospital departments and 1863 outpatient clinics, and contain information on 487 518 patients and 956 634 hospitalizations. RESULTS Heart failure (20%) and stable coronary artery disease (18.5%) were the most frequent primary causes of hospitalization. The number of hospitalizations due to heart failure, aortic stenosis, and pulmonary embolism significantly increased. The highest 12‑month mortality was reported in patients with heart failure and pulmonary embolism (>30%). A decrease in 12‑month mortality in patients with heart failure, stable coronary artery disease, myocardial infarction, and atrial fibrillation was noted, although for some disease entities, it remained relatively high. CONCLUSIONS Between the years 2006 and 2014, in‑hospital and 12‑month mortality showed a trend for decline in many disease entities, with considerable space for prognostic improvement.

Entities:  

Mesh:

Year:  2016        PMID: 27650214     DOI: 10.20452/pamw.3557

Source DB:  PubMed          Journal:  Pol Arch Med Wewn


  10 in total

1.  The Silesian Registry of Out-of-Hospital Cardiac Arrest: Study design and results of a three-month pilot study.

Authors:  Klaudiusz Nadolny; Kamil Bujak; Michał Kucap; Przemysław Trzeciak; Bartosz Hudzik; Artur Borowicz; Mariusz Gąsior
Journal:  Cardiol J       Date:  2018-11-16       Impact factor: 2.737

2.  Prevalence, management and outcomes of cardiac tamponade complicating 66,812 invasive cardiac procedures: single-center clinical registry.

Authors:  Maria Adamczyk; Jacek T Niedziela; Jarosław Wasilewski; Michał O Zembala; Zbigniew Kalarus; Mariusz Gąsior
Journal:  Postepy Kardiol Interwencyjnej       Date:  2021-07-09       Impact factor: 1.426

3.  Multivessel Intervention in Myocardial Infarction with Cardiogenic Shock: CULPRIT-SHOCK Trial Outcomes in the PL-ACS Registry.

Authors:  Mariusz Gąsior; Piotr Desperak; Dariusz Dudek; Adam Witkowski; Paweł E Buszman; Przemysław Trzeciak; Michał Hawranek; Marek Gierlotka; Stanisław Bartuś; Marek Grygier; Michał Zembala; Janina Stępińska; Jacek Legutko; Wojciech Wojakowski
Journal:  J Clin Med       Date:  2021-04-22       Impact factor: 4.241

Review 4.  Prothrombotic Fibrin Clot Phenotype in Patients with Deep Vein Thrombosis and Pulmonary Embolism: A New Risk Factor for Recurrence.

Authors:  Anetta Undas
Journal:  Biomed Res Int       Date:  2017-06-27       Impact factor: 3.411

5.  Baseline characteristics, management and long-term outcomes of different etiologies of cardiac tamponade evaluated in a cohort of 340 patients.

Authors:  Mária Adamczyk; Jarosław Wasilewski; Jacek T Niedziela; Michał O Zembala; Mariusz Gąsior
Journal:  Kardiochir Torakochirurgia Pol       Date:  2022-01-09

6.  Cardiac implantable electronic devices procedures and their recipients characteristic during COVID-19 pandemic: 3.8 million population analysis.

Authors:  Artur Filipecki; Michał Orszulak; Mateusz Tajstra; Oskar Kowalski; Michał Skrzypek; Zbigniew Kalarus; Mariusz Gąsior; Katarzyna Mizia-Stec
Journal:  Cardiol J       Date:  2021-12-21       Impact factor: 2.737

7.  Deep Learning Analysis of Polish Electronic Health Records for Diagnosis Prediction in Patients with Cardiovascular Diseases.

Authors:  Kristof Anetta; Ales Horak; Wojciech Wojakowski; Krystian Wita; Tomasz Jadczyk
Journal:  J Pers Med       Date:  2022-05-25

8.  Transcatheter Versus Surgical Valve Replacement: A 24-months Propensity-matched Analysis of the SILCARD Registry.

Authors:  Krzysztof Wilczek; Michal Hawranek; Wojciech Wojakowski; Piotr Chodór; Michal Zembala; Pawel Buszman; Andrzej Bochenek; Marek Deja; Maciej Dyrbus; Daniel Ciesla; Zbigniew Kalarus; Mariusz Gasior; Marian Zembala
Journal:  Anatol J Cardiol       Date:  2022-03       Impact factor: 1.475

9.  Comparison of coronary artery bypass grafting and percutaneous coronary intervention in patients with heart failure with reduced ejection fraction and multivessel coronary artery disease.

Authors:  Michał Hawranek; Michal O Zembala; Mariusz Gasior; Tomasz Hrapkowicz; Łukasz Pyka; Daniel Cieśla; Marian Zembala
Journal:  Oncotarget       Date:  2018-04-20

10.  Temporal changes in the pattern of invasive angiography use and its outcome in suspected coronary artery disease: implications for patient management and healthcare resources utilization.

Authors:  Jakub Chmiel; Miłosz K Książek; Weronika Stryszak; Paweł Iwaszczuk; Mateusz K Hołda; Grażyna Świtacz; Artur Kozanecki; Piotr Wilkołek; Paweł Rubiś; Grzegorz Kopeć; Piotr Odrowąż-Pieniążek; Tadeusz Przewłocki; Wiesława Tracz; Piotr Podolec; Piotr Musiałek
Journal:  Postepy Kardiol Interwencyjnej       Date:  2018-09-21       Impact factor: 1.426

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.